202
Views
24
CrossRef citations to date
0
Altmetric
Original Article

The Prevalence of Type 2 Idiopathic Macular Telangiectasia in Two African Populations

, , , , , , , & show all
Pages 185-189 | Received 02 Jun 2011, Accepted 23 Aug 2011, Published online: 24 Feb 2012

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Anagha Vaze & Mark Gillies. (2016) Salient features and management options of macular telangiectasia type 2: a review and update. Expert Review of Ophthalmology 11:6, pages 429-441.
Read now
Emily Y. Chew. (2012) How Prevalent is Macular Telangiectasia Type 2?. Ophthalmic Epidemiology 19:4, pages 183-184.
Read now

Articles from other publishers (22)

Lihteh Wu. (2023) Unraveling the mysteries of macular telangiectasia 2: the intersection of philanthropy, multimodal imaging and molecular genetics. The 2022 founders lecture of the pan American vitreoretinal society. International Journal of Retina and Vitreous 9:1.
Crossref
Nikitha Gurram Reddy, Vishma Prabhu, Sumanth Vinayak Sharma, Isha Acharya, Rubble Mangla, Naresh Kumar Yadav, Jay Chhablani, Raja Narayanan & Ramesh Venkatesh. (2023) Baseline demographic, clinical and multimodal imaging features of young patients with type 2 macular telangiectasia. International Journal of Retina and Vitreous 9:1.
Crossref
Lukas Goerdt, Leonie Weinhold, Ben Isselmann, Jose Luis Rodriguez Garcia, Sandrine H. Künzel, Matthias Schmid, Frank G. Holz, Simone Tzaridis & Sarah Thiele. (2023) Relative Ellipsoid Zone Reflectivity in Macular Telangiectasia Type 2. Investigative Opthalmology & Visual Science 64:10, pages 21.
Crossref
Andrew J. Mangum. (2022) Macular Telangiectasia Type 2: Case Report and Clinical Review. CRO (Clinical & Refractive Optometry) Journal 33:2.
Crossref
Mary E. Aronow & Joan W. Miller. 2022. Albert and Jakobiec's Principles and Practice of Ophthalmology. Albert and Jakobiec's Principles and Practice of Ophthalmology 3815 3831 .
Lukas Goerdt, Lydia Sauer, Alexandra S. Vitale, Natalie K. Modersitzki, Monika Fleckenstein & Paul S. Bernstein. (2021) Comparing Fluorescence Lifetime Imaging Ophthalmoscopy in Atrophic Areas of Retinal Diseases. Translational Vision Science & Technology 10:7, pages 11.
Crossref
Simone Tzaridis & Martin Friedlander. (2021) Functional Relevance of Hyper-Reflectivity in Macular Telangiectasia Type 2. Investigative Opthalmology & Visual Science 62:3, pages 6.
Crossref
Matthew R. Starr, Raymond Iezzi & Sophie J. Bakri. (2020) Twenty-Year Incidence of Macular Telangiectasia Type 2 and Associated Systemic Comorbidities in Olmsted County, Minnesota. Ophthalmic Surgery, Lasers and Imaging Retina 51:S2.
Crossref
Lydia Sauer, Alexandra S. Vitale, Karl M. AndersenBarbara Hart & Paul S. Bernstein. (2020) FLUORESCENCE LIFETIME IMAGING OPHTHALMOSCOPY (FLIO) PATTERNS IN CLINICALLY UNAFFECTED CHILDREN OF MACULAR TELANGIECTASIA TYPE 2 (MACTEL) PATIENTS. Retina 40:4, pages 695-704.
Crossref
Sergio Rojas-Juárez & Paola Brito-Sandoval. (2020) Hallazgos en la angiografía por tomografía de coherencia óptica en pacientes mexicanos con telangiectasias maculares tipo 2. Revista Mexicana de Oftalmología 94:2S, pages 77-82.
Crossref
Matthew R. Starr & Sophie J. Bakri. 2020. Choroidal Neovascularization. Choroidal Neovascularization 179 186 .
Mary E. Aronow & Joan W. Miller. 2020. Albert and Jakobiec's Principles and Practice of Ophthalmology. Albert and Jakobiec's Principles and Practice of Ophthalmology 1 18 .
Jason N. Crosson, Thomas A. Swain, Mark E. Clark, Carrie E. Huisingh, Gerald McGwinJr.Jr., Cynthia Owsley & Christine A. Curcio. (2019) Retinal Pathologic Features on OCT among Eyes of Older Adults Judged Healthy by Color Fundus Photography. Ophthalmology Retina 3:8, pages 670-680.
Crossref
Emily Y. Chew, Traci E. Clemons, Glenn J. Jaffe, Charles A. Johnson, Sina Farsiu, Eleonora M. Lad, Robyn Guymer, Philip Rosenfeld, Jean-Pierre Hubschman, Ian Constable, Henry Wiley, Lawrence J. Singerman, Mark Gillies, Grant Comer, Barbara Blodi, Dean Eliott, Jiong Yan, Alan Bird & Martin Friedlander. (2019) Effect of Ciliary Neurotrophic Factor on Retinal Neurodegeneration in Patients with Macular Telangiectasia Type 2. Ophthalmology 126:4, pages 540-549.
Crossref
Simone Müller, Tjebo F.C. Heeren, Jennifer Nadal, Peter Charbel Issa, Philipp Herrmann, Frank G. Holz & Bettina K. Wabbels. (2019) Stereoscopic Vision in Macular Telangiectasia Type 2. Ophthalmologica 241:3, pages 121-129.
Crossref
Paul Bernstein, Chantal Dysli, Jörg Fischer, Martin Hammer, Yoshihiko Katayama, Lydia Sauer & Martin S. Zinkernagel. 2019. High Resolution Imaging in Microscopy and Ophthalmology. High Resolution Imaging in Microscopy and Ophthalmology 213 235 .
Simone Müller, Peter Charbel Issa, Tjebo F.C. Heeren, Sarah Thiele, Frank G. Holz & Philipp Herrmann. (2018) Macular Pigment Distribution as Prognostic Marker for Disease Progression in Macular Telangiectasia Type 2. American Journal of Ophthalmology 194, pages 163-169.
Crossref
Lydia Sauer. (2018) Review of clinical approaches in fluorescence lifetime imaging ophthalmoscopy. Journal of Biomedical Optics 23:09, pages 1.
Crossref
Lydia Sauer, Rebekah H. Gensure, Martin Hammer & Paul S. Bernstein. (2018) Fluorescence Lifetime Imaging Ophthalmoscopy: A Novel Way to Assess Macular Telangiectasia Type 2. Ophthalmology Retina 2:6, pages 587-598.
Crossref
Alexandre MatetSuzanne YzerEmily Y. ChewAlejandra DaruichFrancine Behar-CohenRichard F. Spaide. (2018) CONCURRENT IDIOPATHIC MACULAR TELANGIECTASIA TYPE 2 AND CENTRAL SEROUS CHORIORETINOPATHY. Retina 38:1, pages S67-S78.
Crossref
Martin Pencak, Jan Krasny, Miroslav Veith & Magdalena Vokrojova. (2016) Macular telangiectasia type 2 accompanied by solitary retinal astrocytic hamartoma (case report). BMC Ophthalmology 16:1.
Crossref
Peter Charbel Issa, Mark C. Gillies, Emily Y. Chew, Alan C. Bird, Tjebo F.C. Heeren, Tunde Peto, Frank G. Holz & Hendrik P.N. Scholl. (2013) Macular telangiectasia type 2. Progress in Retinal and Eye Research 34, pages 49-77.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.